Labs / Assays & in vitro testing

MetaCurUm Biotech
Umeå, Sweden · metacurum.se
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
MetaCurUm Biotech develops a preclinical monoclonal antibody therapy for cancer, focused on preventing metastasis by targeting oncogenic TGFβ signaling. The lead program is for metastatic castration-resistant prostate cancer, with plans to extend into other aggressive cancers and related TGFβ indications. It is based in Sweden and is a spin-off from Umeå University.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody drug development
Develops a monoclonal antibody candidate that targets an oncogenic TGFβ signaling pathway for cancer treatment.
Biomarker development
Develops companion biomarkers for patient selection and monitoring treatment effects alongside the lead drug candidate.
What they work on
- Modalities
- Small molecule, Antibody
- Therapeutic areas
- cancer, prostate cancer, breast cancer, lung cancer, kidney cancer, endometrial cancer, fibrosis
- Sites
- Umeå, Sweden
- Serves
- worldwide
- Address
- Enigneering 20 years of experience in Biologics/ATMP and biotech CSO Marén
- Founded
- 2018
Similar labs. ACM Global Laboratories, Allumiqs, AnchorBio Solutions, ARSI Canada Inc
Found in a contract services directory. Listing built from metacurum.se. Work here? Claim this listing.